Centre Hospitalier La Source, Orleans Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01443065
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier La Source-ORLEANS | ORLEANS - Centre Hospitalier La Source

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Colorectal Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 2)

Neoplasms (Phase 2)

Stomach Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 6